Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dahu Health Industry Co has the GF Score of 48, which implies that the company
might have
Worst future performance potential, or not enough data.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Dahu Health Industry Co
might have
Worst future performance potential, or not enough data.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Dahu Health Industry Co (SHSE:600257) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Dahu Health Industry Co GF Score Related Terms
SHSE:600257 vs ADM, BG, TSN: GF Score Comparison
For the Farm Products subindustry, Dahu Health Industry Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dahu Health Industry Co GF Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dahu Health Industry Co's GF Score distribution charts can be found below:
* The bar in red indicates where Dahu Health Industry Co's GF Score falls into.
Dahu Health Industry Co (SHSE:600257) has a GF Score of 48 as of Jul. 27, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Dahu Health Industry Co and its competitors. This is 30% below median its historical median of 69.00. Over the past decade, Dahu Health Industry Co's GF Score has ranged from 52.00 to 82.00.
Is Dahu Health Industry Co's GF Score too high?
Dahu Health Industry Co's current GF Score of 48 is 30% below median its 10-year median of 69.00. Over the past 10 years, this metric has ranged from a low of 52.00 to a high of 82.00. Overall, Dahu Health Industry Co has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dahu Health Industry Co's GF Score compare to ADM and BG?
Dahu Health Industry Co's GF Score of 48 can be compared against companies in the Consumer Packaged Goods industry. Historically, Dahu Health Industry Co's own GF Score has ranged from 52.00 to 82.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Consumer Packaged Goods company?
A good GF Score depends on the Consumer Packaged Goods industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Dahu Health Industry Co and its competitors. Dahu Health Industry Co's current GF Score is 48, which is 30% below median its own 10-year median of 69.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dahu Health Industry Co stock overvalued right now?
Based on GuruFocus' analysis, Dahu Health Industry Co (SHSE:600257) is currently considered Fairly Valued. The stock's GF Value™ is ¥4.47, compared to a current price of ¥4.80 — trading 7.4% above its estimated fair value. The current GF Score is 48, which is 30% below median its 10-year median of 69.00. Dahu Health Industry Co's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Dahu Health Industry Co (SHSE:600257), the current GF Score is 48 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dahu Health Industry Co (SHSE:600257) Overvalued in 2026?
Based on GuruFocus' analysis, Dahu Health Industry Co stock appears to be overvalued.
The current stock price of ¥4.80 is trading 7.4% above its estimated GF Value™ of ¥4.47.
GuruFocus considers Dahu Health Industry Co to be Fairly Valued.
Key valuation signals for SHSE:600257:
GF Score: 48 (30% below median its 10-year median of 69.00)
GF Value™: ¥4.47 vs. price of ¥4.80 (7.4% above fair value)
No single metric tells the full story. See the SHSE:600257 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dahu Health Industry Co Ltd engages in aquatic products and waterfowl breeding, processing, and comprehensive development, alongside foreign investment in proprietary Chinese medicine production and sales. Its operations include medical and food production and sales, nursing, hospital, elderly care, and health services. It also provides artificial intelligence-related technical consulting and system integration, and sells consumer robots.
48GF Score
Get the complete analysis for SHSE:600257
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600257 has been successfully added to your 
